相关实验视频

Updated: Jul 9, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

采用NK细胞疗法 - 在多发性骨髓瘤治疗中的希望之光

Son Hai Vu¹, Ha Hong Pham¹, Thao Thi Phuong Pham¹

¹Hi-Tech Center and Vinmec-VinUni Institute of Immunology, Vinmec Healthcare System, Hanoi, Vietnam.

Frontiers in oncology

|November 29, 2023

概括

化学抗原受体 (CAR) -NK细胞疗法对多发性骨髓瘤 (MM) 显示出前景. 本综述探讨了提高CAR-NK细胞对MM的有效性的策略,解决了改善患者治疗结果的挑战和机会.

科学领域:

血液学和瘤学研究
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

多发性骨髓瘤 (MM) 治疗已经通过新的药物取得了进展,但仍然无法治愈.
细胞免疫疗法,特别是仿真抗原受体 (CAR) 技术,为复发性/耐药性MM提供了新的希望.
CAR-NK细胞疗法在B细胞恶性瘤中取得了成功,但其在MM中的有效性需要进一步调查.

研究的目的:

审查目前用于增强自然杀手 (NK) 细胞基础免疫治疗多发性骨髓瘤的方法.
探索改善NK细胞细胞毒性,持久性,扩张和制造CAR-NK细胞治疗的策略.
突出开发用于MM治疗的CAR-NK细胞疗法的挑战和机遇.

主要方法:

对CAR技术和NK细胞工程方面的进展进行文献综述.
对血液恶性瘤中CAR-NK细胞治疗的临床数据和临床前研究的分析.
探索增强NK细胞功能和治疗多发性骨髓瘤治疗潜力的方法.

主要成果:

在其他B细胞恶性瘤中,CAR-NK细胞疗法已经证明了安全性和有效性.
有各种策略可以改善NK细胞介导的抗髓瘤活性.
对于MM的CAR-NK细胞治疗的挑战包括优化持久性,扩张和制造.

结论:

卡尔-NK细胞疗法作为多发性骨髓瘤的未来治疗方法具有显著的潜力.
需要进一步的研究和开发来克服现有的挑战,并实现CAR-NK细胞对MM的全部治疗潜力.
优化CAR-NK细胞策略可能会改善多发性骨髓瘤患者的治疗结果.

关键词:

采用的NK细胞疗法银行化的细胞.仿制性抗原受体的仿制性抗原受体临床试验是指临床试验中的临床试验.代谢工程是代谢工程.多发性骨髓瘤是多发性骨髓瘤的一种.

更多相关视频

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...